| __timestamp | ACADIA Pharmaceuticals Inc. | Mesoblast Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 25434000 |
| Thursday, January 1, 2015 | 76369000 | 23783000 |
| Friday, January 1, 2016 | 4406000 | 29763000 |
| Sunday, January 1, 2017 | 13060000 | 12065000 |
| Monday, January 1, 2018 | 18330000 | 5508000 |
| Tuesday, January 1, 2019 | 19598000 | 75173000 |
| Wednesday, January 1, 2020 | 20550000 | 81497000 |
| Friday, January 1, 2021 | 19141000 | 85731000 |
| Saturday, January 1, 2022 | 10166000 | 63572000 |
| Sunday, January 1, 2023 | 45731000 | 54922000 |
| Monday, January 1, 2024 | 41070000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, understanding the cost of revenue is crucial for evaluating a company's financial health. ACADIA Pharmaceuticals Inc. and Mesoblast Limited, two prominent players, offer a fascinating case study. Over the past decade, ACADIA's cost of revenue has fluctuated significantly, peaking in 2015 with a 76% increase from the previous year. In contrast, Mesoblast's costs have shown a steady upward trend, culminating in a 237% rise by 2021 compared to 2014.
These trends highlight the strategic decisions each company has made in response to market demands and operational challenges.
Comparing Cost of Revenue Efficiency: Amgen Inc. vs ACADIA Pharmaceuticals Inc.
Regeneron Pharmaceuticals, Inc. vs Mesoblast Limited: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down GSK plc and Mesoblast Limited's Expenses
Takeda Pharmaceutical Company Limited vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Mesoblast Limited
Cost Insights: Breaking Down Catalent, Inc. and ACADIA Pharmaceuticals Inc.'s Expenses
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Mesoblast Limited
Cost Insights: Breaking Down ADMA Biologics, Inc. and ACADIA Pharmaceuticals Inc.'s Expenses
Cost of Revenue: Key Insights for ACADIA Pharmaceuticals Inc. and Taro Pharmaceutical Industries Ltd.
Analyzing Cost of Revenue: ACADIA Pharmaceuticals Inc. and Xencor, Inc.
Analyzing Cost of Revenue: Mesoblast Limited and Taro Pharmaceutical Industries Ltd.